It’s hard to say no to $8 billion. Qualtrics, the enterprise software firm that was on the verge of going public, has pulled its IPO in favor of selling to German software giant SAP for $8 billion in cash.
Qualtrics—which has... Read more »
[Updated 11/12/18, 10:31 am, with deal terms.] Athenahealth has reached an agreement to be bought for approximately $5.7 billion in cash by private equity firms Veritas Capital and Evergreen Coast Capital, an affiliate of activist hedge fund Elliott Management.... Read more »
When Chris Meyer was enveloped by a ball of fire in a construction accident and rushed to a Madison, WI, hospital 14 months ago, his loved ones and friends feared for his life. They also worried about the future of Sector67,... Read more »
Two months ago, the medical community was all abuzz over a big clinical study that showed a prescription fish-oil supplement could reduce the risk of heart disease. Today, a fuller look at the data presents a more nuanced picture.
Doctors working... Read more »
A 10-person team of researchers at the Salk Institute for Biological Studies has been awarded an eight-year, $19.2 million grant to investigate mechanisms underlying Alzheimer’s disease and aging-related cognitive decline and uncover new therapies.
The grant, announced Friday by the research... Read more »
One of the biggest gambles in biotech history is about to be tested on Wall Street.
Moderna, the high-flying yet secretive developer of messenger RNA therapeutics, filed papers on Friday afternoon outlining its long-awaited IPO. In its prospectus, Moderna set an... Read more »
Acquisitions, partnerships, and an FDA approval mark this week’s roundup in Boston technology news. Read on for more:
—Boston University is adding artificial intelligence education to its electrical and computer engineering courses through a partnership with Boston A.I. company Neurala, to... Read more »
The humble cell has been getting a lot of attention in the medical world lately, and Ann Arbor, MI-based biotech startup Celsee wants to make it easier to study them.
As precision medicine and genomic analysis become more sophisticated, clinicians are... Read more »